Staff Profile
Dr Mark Jarvis
Director of Âé¶¹´«Ã½ Advanced Therapies
- Email: mark.jarvis@ncl.ac.uk
- Telephone: 01912824796
- Address: Âé¶¹´«Ã½ Advanced Therapies
Haematological Sciences
Âé¶¹´«Ã½
Framlington Place
Âé¶¹´«Ã½ upon Tyne
NE2 4HH
I am the Director of Âé¶¹´«Ã½ Advanced Therapies with team of skilled scientists, production and quality management staff providing clean room and GMP support for the development of advanced therapy medicinal products (ATMPs) for clinical use and the management and delivery of cellular therapy transplant services. We are an integral part of the Âé¶¹´«Ã½ upon Tyne Hospitals NHS Foundation Trust Pharmacy department and operate under MHRA and HTA approved licences.
Âé¶¹´«Ã½ has long-standing expertise in cellular therapies with a well-established, innovative, haematology transplant service. More recently the Âé¶¹´«Ã½ Hospitals was one of the first Trusts commissioned to be a CAR-T therapy treatment centre. The Âé¶¹´«Ã½ Advanced Therapies has one of the biggest GMP units in Europe, across two sites at the RVI and International Centre for Life, offering processing, storage, development and manufacturing services to support the translation and implementation of advanced therapies. Âé¶¹´«Ã½ Advanced Therapies has a strong track record of delivering ATIMP commercial research and has a dedicated clinical trials manager. The wide range of cellular therapies supported has meant that the NHS Trust has one of the largest and most diverse HTA licenses with the MHRA licence added in 2009.